Koksal C, Kesen N, Akbas U, Kalafat U, Ozkaya K, Okutan M, Fayda M, Küçücük S, Bilge H. Dosimetric comparison of 3-dimensional conformal and intensity-modulated radiotherapy techniques for whole breast irradiation in the prone and supine positions. Int J Radiat Res. 2017; 15 (4) :353-362
Gurdal N, Fayda M, Alishev N, Bakir B, Tastekin D, Aykan F, Gezer U, Balik E, Saglam EK, Oral EN, Gulluoglu M, Kizir A. “Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.” 2017 Dec 6:0. doi: 10.5301/tj.5000702. [Epub ahead of print]
Fayda M., M. Isin, M. Tambas, M. Guveli, R. Meral, M. Altun, D. Sahin, G. Ozkan, Y. Sanli, H. Isin, E. Ozgur ve U. Gezer, “Do Circulating Long Non-Coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) Predict the Treatment Response in Patients with Head and Neck Cancer Treated with Chemoradiotherapy?” Tumour Biol. 2016 Mar;37(3):3969-78
Çakır A., Z. Akgün, E.M. Fayda ve F. Ağaoğlu, “Comparison of three dimensional conformal radiation therapy, intensity modulated radiation therapy and volumetric modulated arc therapy for low radiation exposure of normal tissue in patients with prostate cancer.” Asian Pacific Journal of Cancer Prevention, 16(8), 3365-3370, (2015)
Gürdal N., M. Fayda, B. Bakir, N. Alishev, U. Gezer, D. Tastekin, R. Çiftçi, U. Akbas, D. Sahin, E. Balik, H. Yanar, M. Keskin, M. Ilhan, R.N. Dagoglu, E.K. Saglam, E.N. Oral, F. Aykan ve A. Kizir, “Neoadjuvant Volumetric Modulated Arc Therapy Simultaneous Integrated Boost (SIB-VMAT) With Concurrent Chemotherapy in Rectal Adenocarcinomas and the Correlation of Pathological Response With Diffusion-Weighted MRI and Apoptotic Markers”, American Society for Radiation Oncology 57th Annual Meeting, USA, vol.93(3), pp.E-128, 18-21 October 2015
Gurdal N, Fayda M, Alishev N, Bakir B, Tastekin D, Aykan F, Gezer U, Balik E, Saglam EK, Oral EN, Gulluoglu M, Kizir A. “Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.” 2017 Dec 6:0. doi: 10.5301/tj.5000702. [Epub ahead of print]
Fayda M., M. Isin, M. Tambas, M. Guveli, R. Meral, M. Altun, D. Sahin, G. Ozkan, Y. Sanli, H. Isin, E. Ozgur ve U. Gezer, “Do Circulating Long Non-Coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) Predict the Treatment Response in Patients with Head and Neck Cancer Treated with Chemoradiotherapy?” Tumour Biol. 2016 Mar;37(3):3969-78
Çakır A., Z. Akgün, E.M. Fayda ve F. Ağaoğlu, “Comparison of three dimensional conformal radiation therapy, intensity modulated radiation therapy and volumetric modulated arc therapy for low radiation exposure of normal tissue in patients with prostate cancer.” Asian Pacific Journal of Cancer Prevention, 16(8), 3365-3370, (2015)
Gürdal N., M. Fayda, B. Bakir, N. Alishev, U. Gezer, D. Tastekin, R. Çiftçi, U. Akbas, D. Sahin, E. Balik, H. Yanar, M. Keskin, M. Ilhan, R.N. Dagoglu, E.K. Saglam, E.N. Oral, F. Aykan ve A. Kizir, “Neoadjuvant Volumetric Modulated Arc Therapy Simultaneous Integrated Boost (SIB-VMAT) With Concurrent Chemotherapy in Rectal Adenocarcinomas and the Correlation of Pathological Response With Diffusion-Weighted MRI and Apoptotic Markers”, American Society for Radiation Oncology 57th Annual Meeting, USA, vol.93(3), pp.E-128, 18-21 October 2015